CRELD1 lies in the VEGF-A pathway, and rare variants in CRELD1 and other genes in the VEGF-A pathway modify the risk of CHD in patients with trisomy 21 (Ackerman et al. 2012). This evidence concerns the gene CRELD1 and coronary artery disorder.